172 related articles for article (PubMed ID: 25475439)
1. Salsalate activates brown adipose tissue in mice.
van Dam AD; Nahon KJ; Kooijman S; van den Berg SM; Kanhai AA; Kikuchi T; Heemskerk MM; van Harmelen V; Lombès M; van den Hoek AM; de Winther MP; Lutgens E; Guigas B; Rensen PC; Boon MR
Diabetes; 2015 May; 64(5):1544-54. PubMed ID: 25475439
[TBL] [Abstract][Full Text] [Related]
2. Salsalate treatment improves glycemia without altering adipose tissue in nondiabetic obese hispanics.
Alderete TL; Sattler FR; Richey JM; Allayee H; Mittelman SD; Sheng X; Tucci J; Gyllenhammer LE; Grant EG; Goran MI
Obesity (Silver Spring); 2015 Mar; 23(3):543-51. PubMed ID: 25644856
[TBL] [Abstract][Full Text] [Related]
3. Salsalate and/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice.
Shamshoum H; Medak KD; McKie GL; Jeromson S; Hahn MK; Wright DC
Biomed Pharmacother; 2023 Dec; 168():115671. PubMed ID: 37839107
[TBL] [Abstract][Full Text] [Related]
4. Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus.
Rubin MR; Goldfine AB; McMahon DJ; Donovan DS; Cremers S; Dworakowski E; Schaefer EJ; Shoelson SE; Silverberg SJ
Endocrine; 2015 Nov; 50(2):504-7. PubMed ID: 25636441
[No Abstract] [Full Text] [Related]
5. Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studies.
Anderson K; Wherle L; Park M; Nelson K; Nguyen L
Am Health Drug Benefits; 2014 Jun; 7(4):231-5. PubMed ID: 25126374
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis.
Crane JD; Palanivel R; Mottillo EP; Bujak AL; Wang H; Ford RJ; Collins A; Blümer RM; Fullerton MD; Yabut JM; Kim JJ; Ghia JE; Hamza SM; Morrison KM; Schertzer JD; Dyck JR; Khan WI; Steinberg GR
Nat Med; 2015 Feb; 21(2):166-72. PubMed ID: 25485911
[TBL] [Abstract][Full Text] [Related]
7. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
Berbée JF; Boon MR; Khedoe PP; Bartelt A; Schlein C; Worthmann A; Kooijman S; Hoeke G; Mol IM; John C; Jung C; Vazirpanah N; Brouwers LP; Gordts PL; Esko JD; Hiemstra PS; Havekes LM; Scheja L; Heeren J; Rensen PC
Nat Commun; 2015 Mar; 6():6356. PubMed ID: 25754609
[TBL] [Abstract][Full Text] [Related]
8. White-to-brown metabolic conversion of human adipocytes by JAK inhibition.
Moisan A; Lee YK; Zhang JD; Hudak CS; Meyer CA; Prummer M; Zoffmann S; Truong HH; Ebeling M; Kiialainen A; Gérard R; Xia F; Schinzel RT; Amrein KE; Cowan CA
Nat Cell Biol; 2015 Jan; 17(1):57-67. PubMed ID: 25487280
[TBL] [Abstract][Full Text] [Related]
9. Activation of human brown adipose tissue by a β3-adrenergic receptor agonist.
Cypess AM; Weiner LS; Roberts-Toler C; Franquet Elía E; Kessler SH; Kahn PA; English J; Chatman K; Trauger SA; Doria A; Kolodny GM
Cell Metab; 2015 Jan; 21(1):33-8. PubMed ID: 25565203
[TBL] [Abstract][Full Text] [Related]
10. Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance.
Hanssen MJ; Wierts R; Hoeks J; Gemmink A; Brans B; Mottaghy FM; Schrauwen P; van Marken Lichtenbelt WD
Diabetologia; 2015 Mar; 58(3):586-95. PubMed ID: 25500952
[TBL] [Abstract][Full Text] [Related]
11. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis.
Sidossis L; Kajimura S
J Clin Invest; 2015 Feb; 125(2):478-86. PubMed ID: 25642708
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome profiling of brown adipose tissue during cold exposure reveals extensive regulation of glucose metabolism.
Hao Q; Yadav R; Basse AL; Petersen S; Sonne SB; Rasmussen S; Zhu Q; Lu Z; Wang J; Audouze K; Gupta R; Madsen L; Kristiansen K; Hansen JB
Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E380-92. PubMed ID: 25516548
[TBL] [Abstract][Full Text] [Related]
13. Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers.
Loft A; Forss I; Siersbæk MS; Schmidt SF; Larsen AS; Madsen JG; Pisani DF; Nielsen R; Aagaard MM; Mathison A; Neville MJ; Urrutia R; Karpe F; Amri EZ; Mandrup S
Genes Dev; 2015 Jan; 29(1):7-22. PubMed ID: 25504365
[TBL] [Abstract][Full Text] [Related]
14. A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis.
Stanford KI; Middelbeek RJ; Townsend KL; Lee MY; Takahashi H; So K; Hitchcox KM; Markan KR; Hellbach K; Hirshman MF; Tseng YH; Goodyear LJ
Diabetes; 2015 Jun; 64(6):2002-14. PubMed ID: 25605808
[TBL] [Abstract][Full Text] [Related]
15. Acupuncture promotes white adipose tissue browning by inducing UCP1 expression on DIO mice.
Shen W; Wang Y; Lu SF; Hong H; Fu S; He S; Li Q; Yue J; Xu B; Zhu BM
BMC Complement Altern Med; 2014 Dec; 14():501. PubMed ID: 25514854
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
Owen BM; Mangelsdorf DJ; Kliewer SA
Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
[TBL] [Abstract][Full Text] [Related]
17. Myocardin-related transcription factor A regulates conversion of progenitors to beige adipocytes.
McDonald ME; Li C; Bian H; Smith BD; Layne MD; Farmer SR
Cell; 2015 Jan; 160(1-2):105-18. PubMed ID: 25579684
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of aging-related impairment of brown adipocyte development and function.
Graja A; Schulz TJ
Gerontology; 2015; 61(3):211-7. PubMed ID: 25531079
[TBL] [Abstract][Full Text] [Related]
19. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
